Indications for Posterior Nasal Nerve Ablation
Posterior nasal nerve ablation is indicated for patients with moderate to severe chronic rhinitis (allergic or non-allergic) who have failed conservative medical management, particularly when rhinorrhea and nasal hypersecretion are the predominant symptoms. 1
Primary Indications
The procedure specifically targets patients with:
- Refractory chronic rhinitis with inadequate response to intranasal corticosteroids, antihistamines, and anticholinergic nasal sprays 2, 3
- Persistent rhinorrhea as the dominant symptom, with or without postnasal drip 3
- 24-hour reflective Total Nasal Symptom Score (rTNSS) ≥4 with a rhinorrhea subscore ≥1 2
- Vasomotor (non-allergic) rhinitis with intractable hypersecretion 4
Patient Selection Criteria
Favorable Candidates
- Younger patients (mean age ~28 years) show significantly better outcomes than older patients 1
- Atopic/allergic rhinitis patients demonstrate greater symptom improvement compared to non-allergic patients 1
- Patients who are unwilling or have contraindications to allergen immunotherapy 1
Required Pre-Procedure Failures
Medical therapy must be exhausted before considering ablation, including:
- Intranasal corticosteroids
- Oral antihistamines
- Anticholinergic nasal sprays (ipratropium bromide)
- Reflux treatments (when postnasal drip is present) 3
Exclusions
Patients should not have:
- Prior nasal surgeries (relative contraindication) 2
- Caudal septal deviation requiring correction 2
- Acute or chronic rhinosinusitis 2
- Structural nasal obstruction as the primary complaint (though can be combined with turbinoplasty/septoplasty) 5
Clinical Context
The procedure works by transecting the neural network responsible for excessive nasal secretion, specifically targeting the parasympathetic innervation from the posterior nasal nerve branches. Success rates reach 81% when defined as ≥50% reduction in visual analog scores 1, with 72.5% of patients reporting ≥30% improvement in postnasal drip symptoms 3.
Important Caveats
- Age >50 years is associated with significantly higher failure rates (51.6 vs 28.5 years in successful cases, p=0.05) 1
- The procedure is not a first-line treatment—it requires documented failure of medical management
- While effective for rhinorrhea, the procedure may show less dramatic improvement in sneezing symptoms compared to medical therapy 2
- Safety profile is excellent with only 5.4% reporting transient nasal itching and minimal bleeding complications 1, 5